1.Liang J, Ariizumi SI, Nakano M, Yamamoto M*. Diabetes Mellitus and/or Nonalcoholic
Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes
After Hepatectomy. Anticancer Res. 2019 Oct;39(10):5639-5643.(IF 1.95)
2. Liver cirrhosis in a patient with hepatic hereditary hemorrhagic telangiectasia and
Budd–Chiari syndrome: a case report.BMC Gastroenterology (IF 1.532)1
3. Jing Liang, Fang Liu#, Fengmei Wang*, Tao Han,Li Jing, Zhe Ma,Yingtang Gao. A Noninvasive
Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty
Liver Disease. BioMed Research International .2017,Article ID 8793278, 7 pages.(IF 2.58)
4. Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated
with chronic hepatitis C. Medicine
5.直接抗病毒藥物治療慢性丙型肝炎的效果及對(duì)肝硬度,、APRI的影響.臨床肝膽病雜志.2020
6. 三種炎癥因子在慢性乙型肝炎合并非酒精性脂肪肝的表達(dá)及作用.中華傳染病雜志. 2017.
7.糖尿病與原發(fā)性肝癌:危險(xiǎn)因素還是致病病因,? 臨床肝膽病雜志.2017.
8.《2020年國際肝性腦病和氮代謝學(xué)會(huì)共識(shí):肝性腦病管理中尚未解決的重要問題》摘譯.臨床肝膽病雜志.2020.
|